670
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Development and characterization of arteether-loaded nanostructured lipid carriers for the treatment of malaria

, &
Pages 545-549 | Received 12 Aug 2014, Accepted 12 Sep 2014, Published online: 23 Oct 2014

References

  • Balint GA. 2001. Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacol Ther. 90:261–265.
  • Crawley J, Nahlen B. 2004. Prevention and treatment of malaria in young African children. Semin Pediatr Infect Dis. Elsevier.169–180.
  • Dondorp AM, Day NP. 2007. The treatment of severe malaria. Trans R Soc Trop Med Hyg. 101:633–634.
  • Dutta G, Tripathi R. 2003. New Antimalarial Drug Development in India: Arteether oz/[5-a Blood Schizontocide. Proc Indian natn Sci Acad. B69 No 861–870.
  • Ferone R. 1977. Folate metabolism in malaria. Bull World Health Organ. 55:291.
  • Gkrania-Klotsas E, Lever AM. 2007. An update on malaria prevention, diagnosis and treatment for the returning traveller. Blood Rev. 21:73–87.
  • Klayman DL. 1985. Qinghaosu (artemisinin): an antimalarial drug from China. Science. 228:1049–1055.
  • Krishna AK, Flanagan DR. 1989. Micellar solubilization of a new antimalarial drug, β-arteether. J Pharma Sci. 78:574–576.
  • Oshaghi M, Vatandoost H, Gorouhi A, Abai M, Madjidpour A, Arshi S, et al. 2011. Anopheline species composition in borderline of Iran–Azerbaijan. Acta Trop. 119:44–49.
  • Pople PV, Singh KK. 2011. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus. Eur J Pharm Biopharm. 79:82–94.
  • Vohra T, Kaur I, Heer H, Murthy RR. 2013. Nanolipid carrier-based thermoreversible gel for localized delivery of docetaxel to breast cancer. Cancer Nanotechnol. 4:1–12.
  • Westesen K, Bunjes H, Koch M. 1997. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release. 48:223–236.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.